African Medicines Agency Treaty: National Regulatory Perspectives

New research delves into the slow ratification process of the African Medicines Agency treaty, analyzing perspectives from national regulatory agencies across 45 African countries. Enabling factors like political will and desire for harmonization contrast with challenges such as slow progress and limited understanding. Addressing these can bolster continent-wide medicine regulation, ensuring quality and accessibility for ...

Summer Learning Adventure: Utrecht University’s Global Courses

Gear up for an exhilarating summer with Utrecht University, Netherlands! Join our international summer courses: Pharmacoepidemiology & Drug Safety from July 8-12, 2024, and Pharmaceutical Policy Analysis from July 15-19, 2024. Gain insights, connect globally, and elevate your academic journey! Register now at www.utrechtsummerschool.nl and delve into a summer of growth. For inquiries, contact Emma ...

Urgent Need for Supply Chain Transparency in Healthcare Manufacturing

Labour rights abuse in healthcare product manufacturing is a pressing concern. Data from high-income settings reveal concerning levels of risk, with up to 60% of products sourced from countries with high-risk ratings for labour abuses. Urgent global reforms are needed, emphasizing transparency in supply chains. Ethical procurement practices and supply chain transparency are crucial for ...

WHO’s Essential Tool: Tackling Antimicrobial Resistance with MIA

WHO has released the “WHO List of Medically Important Antimicrobials (MIA)” as a crucial tool to combat antimicrobial resistance (AMR) from non-human use. This guidance supports decision-making for authorities, veterinarians, and agricultural professionals to minimize AMR impact. The MIA categorizes antimicrobials by importance to human medicine, including those authorized exclusively for human use like plazomicin ...

ENABEL Seeks Experts: Join Short-Term Missions Now!

QUAMED member and partner, ENABEL is looking for experts to join their short-term expertise pool ! Once selected, the experts may be mobilized for short missions.  Here is the process: The public procurement for the short-term expertise pool to be set-up within the TESS MAV+ project  is now published – more details here and on TED here. Both consulting ...

Local API Production: Ensuring Medicine Access in Pakistan

Promoting local medicine production in LMICs like Pakistan is vital for ensuring access to essential medications. Active Pharmaceutical Ingredients (APIs) play a crucial role, not just in quality but also in cost. Pakistan’s API promotion Policy is a proactive step, driving growth and ensuring health security. By learning from regional successes and fostering local industries, ...

Raffaella’s Literature Update

Ref:  Qaiser M, Hilton T, Saeed Bukhari SK, Zloh M, Phanouvong S. How a tragedy became a catalyst for sustainable improvement in medicine safety. Lancet Glob Health. 2024 Mar;12(3):e376-e377. Dear Friends,  on …18 July 2012 (!) I shared a short article from the Lancet, “Pakistan’s deadly cocktail of substandard drugs”, analyzing the possible causes of an incident reported ...

Bridging the Gap: Improving Palliative Care Access in Rural Nepal

Palliative care is a lifeline for those with life-threatening illnesses, yet Nepal faces hurdles in accessing essential medications and services, especially in rural areas. Limited studies highlight the demand, but quality healthcare remains out of reach. It’s time for policy changes, including medication inclusion, professional training, and comprehensive research. Together, let’s ensure every patient receives ...

Raffaella’s Literature Update

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Ref. Maharjan P, Ponganam MP, Lambert P, Vogel JP, McIntosh M, McDougall A (2024) The quality of medicines for the prevention and management of hypertensive disorders of pregnancy: A systematic review. PLOS Glob Public Health 4(2): e0002962. Dear ...

Global Concerns: Quality of Pregnancy Hypertension Medicines

The global quality of medicines for preventing and managing hypertensive disorders of pregnancy is concerning. A systematic review of 33 studies from 27 countries found substandard medications across all recommended drugs. Issues included API specification failures, contaminants, pH criteria, degradation, and heavy metal contamination. Urgent action is needed to address safety and efficacy concerns. #MaternalHealth ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.